Brevipil 50 Tablet
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Brivaracetam (50mg)
Overview Brevipil 50 Tablet
Epileptica 50mg tablets are an anticonvulsant medication prescribed to manage epileptic seizures. This medication can be administered independently or in conjunction with other therapies. Consistent use is crucial for ongoing seizure prevention. Epileptica 50mg tablets work by reducing aberrant brain electrical activity. The medication can be taken with or without food, but consistent daily timing optimizes effectiveness. Dosage and frequency are determined by your physician to achieve optimal seizure control, potentially escalating gradually. Long-term use is typically recommended; continue taking it as directed by your doctor, even if you feel well. Discontinuation or missed doses may exacerbate seizures. Never stop taking this medication without consulting your doctor, as abrupt cessation can worsen seizures. Common side effects include vertigo, headache, nausea, and vomiting. Behavioral alterations, including aggression, irritability, and agitation, may also occur. Side effects are frequently more pronounced initially, usually diminishing with continued use. While most side effects are minor, some require medical attention. Suicidal ideation has been reported in a small percentage of patients; inform your physician of any mood deterioration. Prior to commencing treatment, disclose any liver or kidney issues, depression, suicidal thoughts, pregnancy, or pregnancy intentions to your doctor. Nursing mothers should also seek medical advice before use.
Primary Ingredients of Brevipil 50 Tablet
No text provided to rephrase.
Uses of Brevipil 50 Tablet
Convulsive disorders
Major Benefits of Brevipil 50 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Brevipil 50 Tablets can be taken with or without food, although consistent timing is recommended.
Common Side effects of Brevipil 50 Tablet:
- Behavioral changes
- Agitation
- Aggressive behavior
- Dizziness
- Sedation
- Drowsiness
- Neuropsychiatric symptoms
How to use Brevipil 50 Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Brevipil 50 Tablets can be consumed with or without food, though consistent timing is recommended.
How Brevipil 50 Tablet works:
Brevipil 50mg tablets are used to treat epilepsy. Their mechanism of action involves binding to SV2A receptors located on neuronal membranes. This binding reduces excessive neuronal firing in the brain, thereby preventing the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Combining Brevipil 50 Tablet and alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Brevipil 50 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Brevipil 50 Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Brevipil 50 Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Brevipil 50 Tablet poses no safety concerns for patients with kidney impairment; dosage modification is unnecessary. However, its use is contraindicated in end-stage renal disease owing to insufficient clinical evidence.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Brevipil 50 Tablets. Dosage modification may be necessary; physician consultation is recommended.
What if you forget to take Brevipil 50 Tablet :
NA
Facts to Know About Brevipil 50 Tablet
| Label | Value |
|---|---|
| Chemical Category | Levetiracetam Analog |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Behavioral Class | AED: A protein ligand within synaptic vesicle 2 |


